¡Ya estamos en ! Descubre más
NVIV

InVivo Therapeutics Holdings Corp

Excluida de cotización

NVIV dejó de cotizar en bolsa el 12 de febrero de 2024.

 

Acerca de: InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.

Empleados: 6

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 0%
Neutral 0%
Negativo 0%
Gráficos de precios implementados con Lightweight Charts™